Extramural Funding Opportunities

New England Pediatric Device Consortium 2017 Target Challenge RFA

New England Pediatric Device Consortium  (NEPDC) invites grant proposals for the development of novel technologies and improvements to existing technologies to prevent or aid in the prevention of unintended removal of tubes or drains, or unplanned dislodgement of intravenous lines.

Abstracts are due July 7, 2017 and full applications, if invited to do so, would be due July 24, 2017.

Please visit http://nepdc.org/application/target-challenge/ for application instructions.

Abstracts should be submitted by the PI online through the funding agencies application platform. If chosen to do so, full proposals should be submitted with the help of your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management.


Harrington Rare Disease Scholar Award Program

Letters of Intent are being accepted for the Harrington Rare Disease Scholar Award Program. The program is sponsored by Takeda Pharmaceutical Company Ltd and overseen by the Harrington Discovery Institute. The award will provide funding and hands-on drug development guidance for two years to U.S.-based MD and PhD researchers whose discoveries show promise for translation into novel medicines for rare diseases.

For more details please visit the program website.

Letters of Intent are due by July 19, 2017. For those invited to do so, full applications will be due by October 4, 2017.

Letters of Intent should be submitted by the PI online through the funding agencies application platform. If chosen to do so, full proposals should be submitted with the help of your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management.


Drug Discovery Research Grant

Harrington Discovery Institute is now soliciting proposals for the 2018 Harrington Scholar-Innovator Award. The Harrington Scholar-Innovator Award recognizes physician-scientist innovators throughout the U.S. whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development support to help bridge the gap between basic discovery and the clinic. Up to 12 Harrington Scholar-Innovator awards will be made each year through a competitive selection process.

For more details please see the funding institutions webpage.

Letters of Intent are due by Wednesday, April 5, 2017 at 11:59 PM (Midnight) EDT. For those invited to do so, full applications will be due by May 31st, 2017.

Letters of Intent should be submitted by the PI online through the funding agencies application platform. If chosen to do so, full proposals should be submitted with the help of your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management.


Alzheimer’s Research Grant

The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute are pleased to announce the request for proposals for the 2017 ADDF-Harrington Scholar Award. The ADDF-Harrington Scholar Award supports research efforts that seek to prevent, treat or cure Alzheimer’s disease, related dementias and cognitive aging. The award will provide up to $600,000 in funding over two years as well as support for drug development and project management through the Harrington Discovery Institute’s Innovation Support Center Team of pharmaceutical experts.

Interested applicants should see the opportunity announcement here. Letters of Intent are being accepted until 11:59 pm EST March 17, 2017. If chosen to do so, full proposals are due by 11:59 pm EST July 14, 2017.

Letters of Intent should be submitted by the PI online through the funding agencies application platform. If chosen to do so, full proposals should be submitted with the help of your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management.


CPRIT Request for Applications

The Cancer Prevention and Research Institute of Texas (CPRIT), tasked to foster cancer research in Texas by providing financial support for a wide variety of projects relevant to cancer research,  has announced several funding opportunities on their website (http://www.cprit.state.tx.us/funding-opportunities/#research).

These RFAs include but are not limited to:

  1. Individual Investigator Research Awards– Supports applications for innovative research projects addressing critically important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer. Areas of interest include laboratory research, translational studies, and/or clinical investigations. Competitive renewal applications accepted.
    Award: Up to $300,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.
  2. Individual Investigator Research Awards for Cancer in Children and Adolescents– Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, progression, detection, or treatment of cancer in children and adolescents. Laboratory, clinical, or population-based studies are all acceptable. CPRIT expects the outcome of the research to reduce the incidence, morbidity, or mortality from cancer in children and/or adolescents in the near or long term. Competitive renewal applications accepted.
    Award: Up to $300,000 per year. Applicants that plan on conducting a clinical trial as part of the project may request up to $500,000 in total costs. Exceptions permitted if extremely well justified; maximum duration: 4 years.
  3. Individual Investigator Research Awards for Computational Biology– Supports applications for innovative mathematical or computational research projects addressing questions that will advance our knowledge in any aspect of cancer. Areas of interest include data analysis of cellular pathways, microarrays, cellular imaging, cancer imaging or genomic, proteomic, and metabolomic databases; descriptive mathematical models of cancer, as well as mechanistic models of cellular processes and interactions and use of artificial intelligence approaches to build new tools for mining cancer research and treatment databases.
    Award: Up to $300,000 per year. Exceptions permitted if extremely well justified; maximum duration: 3 years.
  4. Individual Investigator Research Awards for Prevention and Early Detection– Supports applications for innovative research projects addressing questions that will advance knowledge of the causes, prevention, early-stage progression, and/or early detection of cancer. Research may be laboratory-, clinical-, or population- based, and may include behavioral/intervention, dissemination or health services/outcomes research to reduce cancer incidence or promote early detection. Competitive renewal applications accepted.
    Award: Up to of $300,000 per year for laboratory and clinical research; Up to $500,000 per year for population-based research. Exceptions permitted if extremely well justified; maximum duration: 3 years.
  5. Individual Investigator Research Awards for Clinical Translation– Supports applications which propose innovative clinical studies that are hypothesis driven and involve patients enrolled prospectively on a clinical trial or involve analyses of biospecimens from patients enrolled on a completed trial for which the outcomes are known. Areas of interest include clinical studies of new or re-purposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices.
    Award: Up to $400,000 per year. Maximum duration: 3 years. Applicants that plan on conducting a clinical trial as part of the project may request up to $600,000 in total costs and a maximum duration of 4 years. Exceptions permitted if extremely well justified.

Deadlines range from March 2, 2017, to July 20, 2017. If you are interested in applying to these or other RFAs from CPRIT please contact your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management.


Homeland Security Grant Division (HSGD) of the Governor’s Office

The Homeland Security Grants Division (HSGD) of the Governor’s Office is soliciting applications for projects that support state and local efforts to prevent terrorism and other catastrophic events and prepare for the threats and hazards that pose the greatest risk to the security of Texas citizens. HSGD provides funding to implement investments that build, sustain, and deliver the 32 core capabilities essential to achieving a secure and resilient state.

Two RFAs have been announced for the 2018 grant cycle. The detailed RFAs can be accessed from the links below:

2017 State Homeland Security Program (SHSP) Request for Applications (RFA) for Law Enforcement Terrorism Prevention Activities (LETPA)

and

2017 State Homeland Security Program (SHSP) RFA for Regular Projects

 

If you are interested in applying please contact your applicable Pre-Award Grant & Contract Analyst (either Rena ‘Niki’ Clarke or Lori O’Neal) in the Office of Grant and Contract Management. Both RFAs have a submission deadline of February 28th, 2017.

 


Clinical Scholars Program

The Center for Translational Medicine at UT Southwestern Medical Center (UTSW) invites competitive applications from UNT Health Science Center for participation in the two-year Clinical Scholars Program.

The Program is designed to provide intense research training and career development opportunities in a multidisciplinary setting that culminate in the submission of an extramural career development grant application.

Candidates with research or health professional doctoral degrees and a strong commitment to clinical and/or translational research are eligible and are encouraged to apply. These include junior faculty, clinical research fellows, and residents who have protected time for research. Deliverables include a completed research project, publishable manuscript, and extramural grant application such as an NIH K award. Scholars will acquire competence in critical thinking, team science, leadership, biomedical statistics, and informatics.

Applications are due December 1, 2016. A link to the 2017 program RFA can be found here.                                                                    

For more information on the program and how to apply please visit the UTSW CTM Clinical Scholars Program page or contact ResearchFunding@unthsc.edu at your earliest convenience.


UT Southwestern Medical Center – Center for Translational Medicine

 

The UT Southwestern Center for Translational Medicine (CTM) is pleased to make available Service Package Grants for various resources from its Translational Pilot Program and throughout the UT Southwestern campus. This program is funded by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), CTSA grant number UL1TR001105. For information on the Service Package grants refer to the Request for Proposal.

The goal of the Translational Pilot Program is to promote and support the development and testing of new research ideas and novel translational ideas of young investigators. The Program will encourage interdisciplinary collaboration and assess the feasibility of new approaches to translational research that will lead to extramural funding.

Trainees and junior faculty at UT Southwestern and investigators at the UNT Health Science Center will have access to funds as they take their first steps in the design and execution of clinical and translational studies.

For more information, contact Sarah Christian
Phone: 214-648-0328


National Institute of Health (NIH) announces a new funding opportunity:

Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies – Complications (DP3)

 

Funding Opportunity Announcement (FOA) Number: RFA-DK-15-019 Purpose: This Funding Opportunity Announcement (FOA) invites applications for studies on the complications of type 1 diabetes using subjects and/or samples from clinical studies on type 1 diabetes.

For key dates and more detailed application information, please visit the original opportunity posting here: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-15-019.html.


Bill & Melinda Gates Foundation

 

The Bill & Melinda Gates Foundation is inviting applications that address specific challenges defined in the grant programs below. For details and application instructions, please visit the new Grand Challenges website. Please note that descriptions of the challenges are available on the website in Chinese, French, Portuguese and Spanish. 1) Grand Challenges Explorations is seeking innovative global health and development solutions and is now accepting proposals for its latest application round. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations, and for-profit companies. Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million. Proposals are being accepted online until November 11, 2015 for the following challenges:

2) New Interventions for Global Health: Vaccine Manufacturing. This challenge focuses on innovations in vaccine manufacturing platforms designed to lower production cost for vaccines that target diseases of great global burden and that are among the most costly to produce with current technologies. Letters of Intent will be accepted until November 5, 2015. Read more about this grant opportunity here.

3) The Global Innovation Fund is accepting application on a rolling basis.  Please visit the website for more information http://globalinnovation.fund/apply-to-gif

4) An Interactive Biostatistics Course will be held from 16-20 November 2015 at the KwaZulu-Natal Research Institute for TB and HIV (K-RITH), based at the Nelson R. Mandela School of Medicine in Durban, South Africa. The primary goal of this course is to give participants an overview of the various biostatistical methods used in medical research so that they can both employ these techniques in their own research and better understand the results presented in medical literature. Lori Chibnik, PhD, MPH, a Biostatistician at Harvard University, will run an inspiring and hands-on training course on biostatistics where students will work with data from their own projects to understand basic statistical concepts and methods used in medical research. Travel Scholarships are available to allow trainees for across Africa to attend. For more information and to apply please visit www.k-rith.org. Deadline for applications:  1 October 2015.

5) In addition, the African Academy of Sciences and the New Partnership for African Development have launched Grand Challenges Africa in Nairobi, Kenya. This program joins others within the Grand Challenges family of grant programs supported by the Bill & Melinda Gates Foundation and its partners. Grand Challenges Africa will build on the global success of Grand Challenges programs in India, Brazil, and South Africa, as well as the strong base of Africa Grand Challenges grantees already funded by the Bill & Melinda Gates Foundation, Grand Challenges Canada, and USAID. Please read our latest blogs including one from the Global Health President. For more information please visit AAS.

Furthermore, as a forum for sharing ideas, pursuing new opportunities and keeping abreast of new developments in the field of global health, The Gates Foundation together with Grand Challenges Canada has set-up a LinkedIn group. All you need to join is a free LinkedIn account – go to Global Health Innovations and click “Join”

 

 

This page was last modified on June 26, 2017